Highlights
tumor
METASTATIC COLORECTAL CANCER, TUMOR, METASTATIC COLORECTAL CANCER, SENSITIVITY
Metastatic colorectal cancer patients (Drug assays were successfully tested in tumor derived organoids of metastatic colorectal cancer patients.Sensitivity drug tests performed in tumor derived organoids pointed out specific treatment for individual patients.A total of 34 patients initiated the treatment according to the drug assay results.Progression-free survival at two months was met in 17 of 34 patients exceeding the pre-defined minimal relevant difference to historical controls from randomized trials.